Sarah Brown
0000-0002-7975-7537
3 papers found
Refreshing results…
A Road Map for Designing Phase I Clinical Trials of Radiotherapy–Novel Agent Combinations
MUKnine OPTIMUM protocol: a screening study to identify high-risk patients with multiple myeloma suitable for novel treatment approaches combined with a phase II study evaluating optimised combination of biological therapy in newly diagnosed high-risk multiple myeloma and plasma cell leukaemia
Bortezomib, vorinostat and dexamethasone combination therapy in relapsed myeloma: results of the phase 2 MUK trial WQZa
Missing publications? Search for publications with a matching author name.